Trial · NCT01647542
Results by group21
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 21
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in HbA1c at Week 24 | Placebo | Baseline (n= 120, 124, 131) | 7.99 | Standard Error 0.104 | Percentage of Glycosylated Hemoglobin |
| Change From Baseline in HbA1c at Week 24 | Fasiglifam 25 mg | Baseline (n= 120, 124, 131) | 7.94 | Standard Error 0.101 | Percentage of Glycosylated Hemoglobin |
| Change From Baseline in HbA1c at Week 24 | Fasiglifam 50 mg | Baseline (n= 120, 124, 131) | 7.91 | Standard Error 0.102 | Percentage of Glycosylated Hemoglobin |
| Change From Baseline in HbA1c at Week 24 | Placebo | Change at Week 24 (n= 52, 61, 59) | 0.15 | Standard Error 0.101 | Percentage of Glycosylated Hemoglobin |
| Change From Baseline in HbA1c at Week 24 | Fasiglifam 25 mg | Change at Week 24 (n= 52, 61, 59) | -0.67 | Standard Error 0.097 | Percentage of Glycosylated Hemoglobin |
| Change From Baseline in HbA1c at Week 24 | Fasiglifam 50 mg | Change at Week 24 (n= 52, 61, 59) | -0.87 | Standard Error 0.097 | Percentage of Glycosylated Hemoglobin |
| Percentage of Participants With HbA1c <7% at Week 24 | Placebo | 20.0 | Percentage of participants | ||
| Percentage of Participants With HbA1c <7% at Week 24 | Fasiglifam 25 mg | 42.7 | Percentage of participants | ||
| Percentage of Participants With HbA1c <7% at Week 24 | Fasiglifam 50 mg | 52.7 | Percentage of participants | ||
| Change in Fasting Plasma Glucose From Baseline to Week 24 | Placebo | Baseline (n =129, 127, 129) | 152.4 | Standard Error 4.74 | Milligram per deciliter (mg/dL) |
| Change in Fasting Plasma Glucose From Baseline to Week 24 | Fasiglifam 25 mg | Baseline (n =129, 127, 129) | 152.4 | Standard Error 4.67 | Milligram per deciliter (mg/dL) |
| Change in Fasting Plasma Glucose From Baseline to Week 24 | Fasiglifam 50 mg | Baseline (n =129, 127, 129) | 149.7 | Standard Error 4.74 | Milligram per deciliter (mg/dL) |
| Change in Fasting Plasma Glucose From Baseline to Week 24 | Placebo | Change at Week 24 (n = 51, 58, 57) | 15.1 | Standard Error 3.59 | Milligram per deciliter (mg/dL) |
| Change in Fasting Plasma Glucose From Baseline to Week 24 | Fasiglifam 25 mg | Change at Week 24 (n = 51, 58, 57) | -20.6 | Standard Error 3.42 | Milligram per deciliter (mg/dL) |
| Change in Fasting Plasma Glucose From Baseline to Week 24 | Fasiglifam 50 mg | Change at Week 24 (n = 51, 58, 57) | -20.4 | Standard Error 3.45 | Milligram per deciliter (mg/dL) |
| Change From Baseline in 2-hour Postprandial Glucose (PPG) Following Oral Glucose Tolerance Test (OGTT) at Week 24 | Placebo | Baseline | 150.3 | Standard Error 21.69 | mg/dL |
| Change From Baseline in 2-hour Postprandial Glucose (PPG) Following Oral Glucose Tolerance Test (OGTT) at Week 24 | Fasiglifam 25 mg | Baseline | 121.2 | Standard Error 22.76 | mg/dL |
| Change From Baseline in 2-hour Postprandial Glucose (PPG) Following Oral Glucose Tolerance Test (OGTT) at Week 24 | Fasiglifam 50 mg | Baseline | 129.0 | Standard Error 18.72 | mg/dL |
| Change From Baseline in 2-hour Postprandial Glucose (PPG) Following Oral Glucose Tolerance Test (OGTT) at Week 24 | Placebo | Change at Week 24 | 3.7 | Standard Error 24.58 | mg/dL |
| Change From Baseline in 2-hour Postprandial Glucose (PPG) Following Oral Glucose Tolerance Test (OGTT) at Week 24 | Fasiglifam 25 mg | Change at Week 24 | -21.2 | Standard Error 25.98 | mg/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01647542/results